LivaNova PLC (LIVN.OQ)
17 Nov 2017
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
- BRIEF-LivaNova Plc reports Q3 diluted earnings per share were $0.57
- BRIEF-Livanova receives FDA approval for Vagus Nerve Stimulation Therapy system
- BRIEF-Livanova and Microport announce approval of Rega pacemakers by China FDA
- BRIEF-Livanova announces U.S. Launch of Optiflow Arterial Cannulae Family
- BRIEF-LivaNova expects to achieve revenue growth in mid-single-digits in near term and high-single-digits in long term